Search


	Podcast:		BioCentury This Week
	Episode:		Ep. 103 - Califf’s priorities for second stint as FDA Commissioner
	Category:		Science & Medicine
	Duration:		00:22:39
	Publish Date:		2022-02-23 00:00:00
	Description:		Newly confirmed FDA commissioner Rob Califf will be prioritizing a proactive communications strategy, including combating misinformation about science, whilst guiding FDA through the pandemic and trying to keep the agency above Washington’s political fray. Plus, BioCentury’s editors discuss how late-stage investors are adapting to biotech’s bull market and Amgen’s application of its rapid development strategy to its pipeline. Sponsored by Jeito Capital, a global leading investment company with a patient benefit driven approach that finances and accelerates the development and growth of ground-breaking innovation. Learn more at Jeito Capital. Dig deeper into BioCentury’s analysis of these issues and more at BioCentury.
	Total Play:		0